ペプチドリームの株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2025/03/05 | 2,185 | 2,207.5 | 2,108 | 2,175 | +64.5 | +3.1% | 842,500 |
2025/03/04 | 2,111.5 | 2,252 | 2,084 | 2,110.5 | +60.5 | +3% | 1,516,100 |
2025/03/03 | 2,007 | 2,071 | 1,978 | 2,050 | +14.5 | +0.7% | 929,100 |
2025/02/28 | 2,050 | 2,065 | 1,989 | 2,035.5 | -47.5 | -2.3% | 858,000 |
2025/02/27 | 2,139 | 2,190 | 2,068.5 | 2,083 | +28.5 | +1.4% | 864,800 |
2025/02/26 | 2,038.5 | 2,115 | 2,038.5 | 2,054.5 | +34.5 | +1.7% | 890,600 |
2025/02/25 | 2,050 | 2,050 | 1,983 | 2,020 | -96 | -4.5% | 868,000 |
2025/02/21 | 2,090 | 2,127 | 2,075 | 2,116 | +24 | +1.1% | 631,500 |
2025/02/20 | 2,197 | 2,220 | 2,092 | 2,092 | -56 | -2.6% | 664,300 |
2025/02/19 | 2,180 | 2,185 | 2,143.5 | 2,148 | -59 | -2.7% | 770,200 |
2025/02/18 | 2,205 | 2,267 | 2,191 | 2,207 | -4 | -0.2% | 750,800 |
2025/02/17 | 2,328 | 2,335 | 2,169 | 2,211 | -116.5 | -5% | 1,394,500 |
2025/02/14 | 2,389 | 2,389 | 2,194.5 | 2,327.5 | +338 | +17% | 3,962,500 |
2025/02/13 | 1,960 | 1,998 | 1,940 | 1,989.5 | +57 | +2.9% | 731,300 |
2025/02/12 | 1,968.5 | 1,969 | 1,897 | 1,932.5 | -36.5 | -1.9% | 892,800 |
2025/02/10 | 1,940 | 1,975 | 1,937 | 1,969 | +17.5 | +0.9% | 572,500 |
2025/02/07 | 1,994 | 2,001 | 1,938.5 | 1,951.5 | -62.5 | -3.1% | 751,700 |
2025/02/06 | 1,989 | 2,050 | 1,985.5 | 2,014 | +28.5 | +1.4% | 731,200 |
2025/02/05 | 1,972 | 1,993.5 | 1,939 | 1,985.5 | -3 | -0.2% | 682,800 |
2025/02/04 | 2,014 | 2,033 | 1,954.5 | 1,988.5 | -11.5 | -0.6% | 1,008,000 |
2025/02/03 | 2,061 | 2,084.5 | 1,994 | 2,000 | -146 | -6.8% | 912,300 |
2025/01/31 | 2,156 | 2,185.5 | 2,143 | 2,146 | -1 | ±0% | 508,900 |
2025/01/30 | 2,146.5 | 2,178 | 2,132.5 | 2,147 | +2 | +0.1% | 468,300 |
2025/01/29 | 2,149 | 2,195.5 | 2,113 | 2,145 | +20.5 | +1% | 941,400 |
2025/01/28 | 2,110.5 | 2,127 | 2,075.5 | 2,124.5 | +30.5 | +1.5% | 539,000 |
2025/01/27 | 2,152.5 | 2,181.5 | 2,091.5 | 2,094 | -45 | -2.1% | 731,100 |
2025/01/24 | 2,113 | 2,148.5 | 2,095.5 | 2,139 | +47.5 | +2.3% | 680,900 |
2025/01/23 | 2,170 | 2,175 | 2,081 | 2,091.5 | -43 | -2% | 941,100 |
2025/01/22 | 2,212 | 2,229 | 2,105 | 2,134.5 | -55.5 | -2.5% | 913,200 |
2025/01/21 | 2,206 | 2,252 | 2,155 | 2,190 | +6 | +0.3% | 814,700 |
2025/01/20 | 2,134 | 2,188.5 | 2,117 | 2,184 | +71 | +3.4% | 751,700 |
2025/01/17 | 2,139 | 2,238.5 | 2,110.5 | 2,113 | +2 | +0.1% | 1,354,000 |
2025/01/16 | 2,173 | 2,182.5 | 2,101 | 2,111 | -33.5 | -1.6% | 774,400 |
2025/01/15 | 2,267 | 2,268 | 2,122 | 2,144.5 | -146.5 | -6.4% | 1,259,000 |
2025/01/14 | 2,297.5 | 2,328 | 2,267.5 | 2,291 | -56.5 | -2.4% | 667,600 |
2025/01/10 | 2,368.5 | 2,398 | 2,295 | 2,347.5 | -69 | -2.9% | 1,053,300 |
2025/01/09 | 2,440 | 2,461 | 2,413.5 | 2,416.5 | -53.5 | -2.2% | 680,800 |
2025/01/08 | 2,470 | 2,520 | 2,467 | 2,470 | -31 | -1.2% | 553,800 |
2025/01/07 | 2,497.5 | 2,524.5 | 2,465 | 2,501 | -16 | -0.6% | 705,300 |
2025/01/06 | 2,629 | 2,629 | 2,517 | 2,517 | -127.5 | -4.8% | 762,600 |
2024/12/30 | 2,616 | 2,651.5 | 2,583.5 | 2,644.5 | +28.5 | +1.1% | 555,700 |
2024/12/27 | 2,590 | 2,634 | 2,570.5 | 2,616 | +55 | +2.1% | 622,600 |
2024/12/26 | 2,560 | 2,580 | 2,535 | 2,561 | -22 | -0.9% | 590,200 |
2024/12/25 | 2,620 | 2,635 | 2,518.5 | 2,583 | +25.5 | +1% | 662,000 |
2024/12/24 | 2,585 | 2,607 | 2,552 | 2,557.5 | +6.5 | +0.3% | 540,000 |
2024/12/23 | 2,542 | 2,566.5 | 2,510 | 2,551 | -19 | -0.7% | 664,300 |
2024/12/20 | 2,622 | 2,639 | 2,552 | 2,570 | -37 | -1.4% | 867,300 |
2024/12/19 | 2,573 | 2,668 | 2,561.5 | 2,607 | -10.5 | -0.4% | 626,900 |
2024/12/18 | 2,600 | 2,658 | 2,574.5 | 2,617.5 | +22 | +0.8% | 880,900 |
2024/12/17 | 2,580 | 2,595.5 | 2,490.5 | 2,595.5 | +15 | +0.6% | 1,122,600 |
51~
100
件表示中 / 2917件
類似銘柄と比較する
現在ご覧いただいている「ペプチド」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
ペプチド | 172,500円 | +5.0% | +1.5% | 0.00% | 14.75倍 | 3.93倍 |
|
東大発のペプチド創薬ベンチャーの雄。海外製薬大手との提携多数。買収で放射性医薬品に参入 |
サンバイオ | 333,000円 | - | - | 0.00% | - | 154.23倍 |
|
脳疾患向け再生細胞薬の開発・製造・販売目指すバイオベンチャー。米国で創業し日本に逆上陸 |
日本新薬 | 342,900円 | +8.0% | -15.3% | 3.62% | 9.63倍 | 0.94倍 |
|
医家向け医薬品主体、自社創薬は泌尿器科、血液内科、難病・希少疾患に集中。機能食品も育成 |
サワイGHD | 177,400円 | +5.9% | +24.5% | 3.10% | 11.77倍 | 1.11倍 |
|
ジェネリック(後発)薬大手メーカー。21年春に沢井製薬が持株会社化。大型買収で米国本格展開 |
キッセイ薬 | 388,000円 | +3.6% | +6.1% | 3.09% | 13.07倍 | 0.77倍 |
|
医薬品中堅。泌尿器、腎・透析、未充足医療が重点領域。主軸特許切れ、新しい柱育成。海外は導出 |
市場注目の銘柄
チャート関連のコラム